CytoSorbents Reports First Quarter 2022 Results and Revises

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

Related Keywords

Ireland , United States , United Kingdom , State Of New Jersey , New Jersey , Luxembourg , Austria , Russia , Brussels , Bruxelles Capitale , Belgium , London , City Of , Ukraine , Germany , Italy , Spain , France , German , Russian , Jiny Kim , Eric Kim , Phillip Chan , Buildout Of The Company , Euroelso Congress , Twitter , Material Command , European Union , Facebook , Us Army , Blood Institute , National Heart , Cytosorbents Corporation , Asklepios Group , International Safe , Us Department Of Health , Human Services , National Institutes Of Health , Us Air , Company Form , International Journal Of Artificial Organs , International Symposium On Intensive Care , Corporate Communications , Timely Antithrombotic Removal , Direct Oral Anticoagulants , Removal System , Notified Body , Data Publications , Cytosorb Therapy , Use Authorization , International Symposium , Intensive Care , Emergency Medicine , Cytosorbents Lunch , Chief Executive Officer , Bridge Bank , Critical Care , New Applications , Data Safety Monitoring Board , Cardiovascular Surgery , Expert Review , Cardiovascular Therapy , Vascular Anesthesia , Sorb Therapy , Septic Shock , German Hep On Fire , International Journal , Artificial Organs , Blood Purification , German Customs Authorities , Call Details , Investor Relations , Sorbents Corporation , Timely Antithromboticremoval Ticagrelor , National Institutes , Operations Command , Air Force Material Command , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Three Months , Relations Contact ,